H1 sales grew by 8.6% as reported (+5.3% at CER); EBITDA increased by 20.2%, EBIT by 23.4% and consolidated profit after non-controlling interests by 59.7%.
31 May 2016
Strong H1, boosted by forex
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Strong H1, boosted by forex
Carl Zeiss Meditec AG (AFX:WBO) | 0 0 1.8% | Mkt Cap: 4,494m
- Published:
31 May 2016 -
Author:
Armelle Moulin -
Pages:
2
H1 sales grew by 8.6% as reported (+5.3% at CER); EBITDA increased by 20.2%, EBIT by 23.4% and consolidated profit after non-controlling interests by 59.7%.